Instil Bio Inc (TIL): A note about Instil's Competition, I...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	113
Posts	16405
Boards Moderated	0
Alias Born	05/22/2011

Watts Watt

Re: None

Thursday, 09/23/2021 9:54:15 AM

Thursday, September 23, 2021 9:54:15 AM

A note about Instil's Competition, Iovance and their latest news:

http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210923:nGNX2fMDMm&default-theme=true

And the stunning truth of the matter is that this generation, save the military, doesn’t value freedom. Instead, it values comfort. It values convenience and coddling, and conformity.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent TIL News

Instil Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/21/2024 09:00:58 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:08:17 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 10:36:52 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 12:01:42 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 10:00:34 PM
Instil Bio Announces Strategic Update • GlobeNewswire Inc. • 01/16/2024 01:00:27 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 01:10:49 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 12:49:04 AM
Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2023 10:00:31 PM
Instil Bio Announces Effective Date of 1-for-20 Reverse Stock Split • GlobeNewswire Inc. • 12/05/2023 10:00:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2023 12:13:52 PM
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 11/13/2023 10:27:05 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 10:03:23 PM
Instil Bio Reports Third Quarter 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/13/2023 10:00:57 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 10:00:35 PM
Instil Bio Announces Poster Presentations of ITIL-306 Preclinical Data at SITC 2023 Annual Meeting • GlobeNewswire Inc. • 11/06/2023 12:00:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 11:05:14 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 11:01:00 AM
Instil Bio Reports Second Quarter 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 08/14/2023 11:00:15 AM
Instil Bio Announces Oral Presentation of ITIL-306 Preclinical Data at British Society for Gene and Cell Therapy Annual Conference • GlobeNewswire Inc. • 06/26/2023 08:38:04 PM
Instil Bio Reports First Quarter 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/11/2023 11:00:00 AM

More TIL News

InvestorsHub NewsWire

FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover